Major milestone for WHO-supported #Ebola vaccine rVSV-ZEBOV-GP as it moves closer to licensing, following positive opinion from @EMA_News bit.ly/35JvOQP 
@EMA_News @OMSRDCONGO @pahowho In the past five years, WHO has convened experts to review the evidence on various #Ebola vaccine candidates, informed policy recommendations, and mobilized a multilateral coalition to accelerate clinical evaluations.
bit.ly/35JvOQP
bit.ly/35JvOQP
@EMA_News @OMSRDCONGO @pahowho A randomized trial for the rVSV-ZEBOV-GP vaccine began during the West Africa #Ebola outbreak in 2015.
When no other organization was positioned to run a trial in #Guinea during the complex emergency, the government of Guinea and WHO took the unusual step to lead the trial.
When no other organization was positioned to run a trial in #Guinea during the complex emergency, the government of Guinea and WHO took the unusual step to lead the trial.
@EMA_News @OMSRDCONGO @pahowho A global coalition of funders & researchers provided the critical support required for the trial. Funders incl. 🇨🇦 through @PHAC_GC, @CIHR_IRSC, @IDRC_CRDI, @GAC_Corporate; 🇳🇴 through @forskningsradet's GLOBVAC programme; @wellcometrust; 🇬🇧 @DFID_UK & @MSF.
@EMA_News @OMSRDCONGO @pahowho @PHAC_GC @CIHR_IRSC @IDRC_CRDI @GAC_Corporate @forskningsradet @wellcometrust @DFID_UK @MSF Anticipating that in coming years there will be higher #Ebola vaccine demand during and between outbreaks. WHO is working with @gavi, @UNICEF and other partners to develop a Global Ebola Vaccines Security Plan.
bit.ly/35JvOQP
bit.ly/35JvOQP
@EMA_News @OMSRDCONGO @pahowho @PHAC_GC @CIHR_IRSC @IDRC_CRDI @GAC_Corporate @forskningsradet @wellcometrust @DFID_UK @MSF @gavi @UNICEF There are 8 #Ebola vaccines undergoing clinical evaluation. WHO continues to work with partners towards an internationally coordinated governing mechanism to ensure access according to risk criteria, and manage supply and stockpiles.
bit.ly/35JvOQP
bit.ly/35JvOQP
